
Results
2
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
2 companies
Medexus Pharmaceuticals
Market Cap: CA$128.6m
Medexus Pharmaceuticals Inc. opera como empresa farmacéutica en Canadá y Estados Unidos.
MDP
CA$4.20
7D
0%
1Y
33.3%
Cardiol Therapeutics
Market Cap: CA$174.1m
Cardiol Therapeutics Inc, empresa de ciencias de la vida en fase clínica, se centra en el desarrollo de terapias antifibróticas y antiinflamatorias para el tratamiento de enfermedades cardiacas.
CRDL
CA$1.51
7D
0.3%
1Y
-21.6%